Free Trial

Protalix BioTherapeutics (PLX) Insider Trading & Ownership

Protalix BioTherapeutics logo
$2.01 +0.08 (+3.94%)
As of 09:59 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Protalix BioTherapeutics (NYSE:PLX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
6.50%
Number Of
Insiders Buying
(Last 12 Months)
2
Amount Of
Insider Buying
(Last 12 Months)
$307.76K
Number Of
Insiders Selling
(Last 12 Months)
1
Amount Of
Insider Selling
(Last 12 Months)
$628.32
Get PLX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Protalix BioTherapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

PLX Insider Buying and Selling by Quarter

Protalix BioTherapeutics Insider and Congressional Trades History

Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/19/2025
Dror Bashan
CEO
Buy56,000$1.81$101,360.00  
11/18/2025
Amos Bar-Shalev
Director
Sell168$1.87$314.16  
11/18/2025
Amos Bar-Shalev
Director
Sell168$1.87$314.16  
6/10/2025
Aharon Schwartz
Director
Buy129,000$1.60$206,400.00  
(Data available from 1/1/2013 forward)

PLX Insider Trading Activity - Frequently Asked Questions

The list of insiders at Protalix BioTherapeutics includes Aharon Schwartz, Amos Bar-Shalev, and Dror Bashan. Learn more on insiders at PLX.

6.50% of Protalix BioTherapeutics stock is owned by insiders. Learn more on PLX's insider holdings.

The following insiders have purchased PLX shares in the last 24 months: Aharon Schwartz ($206,400.00), and Dror Bashan ($101,360.00).

Insiders have purchased a total of 185,000 PLX shares in the last 24 months for a total of $307,760.00 bought.

The following insider sold PLX shares in the last 24 months: Amos Bar-Shalev ($628.32).

Insiders have sold a total of 336 Protalix BioTherapeutics shares in the last 24 months for a total of $628.32 sold.



This page (NYSE:PLX) was last updated on 5/14/2026 by MarketBeat.com Staff.
From Our Partners